Everything is relative. If we have 140 million shares outstanding, we will get a decent share price if we have sufficient revs and eps. I don't think we automatically get a higher p/e ratio with 50 million or 140 million.
The lower share count May lead to a higher share price but it doesn't always work. I would rather see the company focus and concentrate on increasing real business and continue to minimize future dilution.
Share price X shares = Total market cap. I don't see how reducing share count will increase market cap. Plus sometimes they do the wrong thing to finance the reduced share count and cause other financing or future dilution problems.
.11 X 140 million = 15.4million
.33 X 47 million = 15 million
The only thing wrong with Labwire is their pink sheet listing and higher revs and eps. The more Dexter focuses on revs and eps, the better I will like it. I can use a calculator and figure out that .003/qtr eps with 140 million outstanding is the same as .009/qtr eps with 46.667million outstanding.
Bobwins
News 
Market Data 
Discover 
